Skip to main content
OpenTrials
Completed

NCT Number: NCT05266885

Prevalence of Hypertension in Type-2 Diabetes Mellitus

Cardiovascular disease is the most prevalent cause of morbidity and mortality in diabetic patients. Hypertension has been confirmed as a major risk factor for cardiovascular disease, which is frequently associated with diabetes mellitus. Therefore, the detection and management of elevated blood pressure (BP) is a critical component of the comprehensive clinical management of diabetics. Since the rates of hypertension in diabetics are lacking in Afghanistan, this study aimed to evaluate the prevalence of elevated blood pressure in type-2 diabetic patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Prevalence of Elevated Blood Pressure in Type-2 Diabetics Cardiovascular Diseases Hypertension Vascular Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Habib Ahmad Esmat

Kabul, None Selected, 35030, Afghanistan

About this study

Cardiovascular disease is the most prevalent cause of morbidity and mortality in diabetic patients. Hypertension has been confirmed as a major risk factor for cardiovascular disease, which is frequently associated with diabetes mellitus. Therefore, the detection and management of elevated blood pressure (BP) is a critical component of the comprehensive clinical management of diabetics. Since the rates of hypertension in diabetics are lacking in Afghanistan, this study aimed to evaluate the prevalence of elevated blood pressure in type-2 diabetic patients.

This is a descriptive cross-sectional study, which included 322 type -2 diabetic patients (37 male, 63 female) who were presented to our center from November 2019 to January 2020.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinically diagnosed diabetic patients
  • Newly diagnosed Diabetics
  • known case of diabetes

Exclusion criteria

  • The patients who were seriously ill
  • Pregnant women
  • Type-1 diabetic patients,

Treatment and study plan

Primary outcomes

  1. High incidence of HTN in Diabetics

    Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Kabul University of Medical Sciences

Other

Registry information

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Mar 4, 2022
Registry last updated
Mar 4, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.